The introduction of the Retatru vial represents a significant breakthrough in the approach to body management . This novel therapy combines two distinct mechanisms – agonist of the GLP-1 receptor and reduction of the DPP-4 factor – offering a unique method for addressing obesity . Early research results indicate promising effectiveness in promo